US Equity
ABBV
— ABBVIE INC.AbbVie is a research-based biopharmaceutical company focused on developing treatments for immunology, oncology, neuroscience, and other therapeutic areas.
💰 Market cap: $453.91B📍 1 N Waukegan Rd, NORTH CHICAGO, IL, 60064 US🏷️ Pharmaceuticals💵 Previous close: $259.36🔢 9,756 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $259.36 |
| 2026-07-23 | $256.92 |
| 2026-07-22 | $253.30 |
| 2026-07-21 | $256.10 |
| 2026-07-20 | $253.38 |
| 2026-07-17 | $254.49 |
| 2026-07-16 | $254.39 |
| 2026-07-15 | $244.11 |
| 2026-07-14 | $244.78 |
| 2026-07-13 | $248.00 |
| 2026-07-10 | $248.08 |
| 2026-07-09 | $249.91 |
| 2026-07-08 | $252.74 |
| 2026-07-07 | $254.65 |
| 2026-07-06 | $254.76 |
| 2026-07-02 | $261.07 |
| 2026-07-01 | $251.06 |
| 2026-06-30 | $251.64 |
| 2026-06-29 | $254.31 |
| 2026-06-26 | $253.35 |
| 2026-06-25 | $243.14 |
| 2026-06-24 | $234.89 |
| 2026-06-23 | $234.76 |
| 2026-06-22 | $230.01 |
| 2026-06-18 | $216.49 |
| 2026-06-17 | $221.23 |
| 2026-06-16 | $222.47 |
| 2026-06-15 | $221.59 |
| 2026-06-12 | $227.73 |
| 2026-06-11 | $224.77 |
| 2026-06-10 | $224.95 |
| 2026-06-09 | $225.42 |
| 2026-06-08 | $223.07 |
| 2026-06-05 | $227.23 |
| 2026-06-04 | $224.94 |
| 2026-06-03 | $217.13 |
| 2026-06-02 | $215.40 |
| 2026-06-01 | $212.93 |
| 2026-05-29 | $217.72 |
| 2026-05-28 | $218.63 |
| 2026-05-27 | $215.40 |
| 2026-05-26 | $213.12 |
| 2026-05-22 | $215.70 |
| 2026-05-21 | $214.50 |
| 2026-05-20 | $212.30 |
| 2026-05-19 | $213.76 |
| 2026-05-18 | $209.41 |
| 2026-05-15 | $210.39 |
| 2026-05-14 | $210.77 |
| 2026-05-13 | $208.50 |
| 2026-05-12 | $207.86 |
| 2026-05-11 | $202.78 |
| 2026-05-08 | $201.55 |
| 2026-05-07 | $202.71 |
| 2026-05-06 | $205.03 |
| 2026-05-05 | $206.11 |
| 2026-05-04 | $208.16 |
| 2026-05-01 | $206.60 |
| 2026-04-30 | $211.32 |
| 2026-04-29 | $203.89 |
| 2026-04-28 | $197.69 |